Your browser doesn't support javascript.
loading
Preclinical development of a first-in-class vaccine encoding HER2, Brachyury and CD40L for antibody enhanced tumor eradication.
Hinterberger, Maria; Endt, Kathrin; Bathke, Barbara; Habjan, Matthias; Heiseke, Alexander; Schweneker, Marc; Von Rohrscheidt, Julia; Atay, Cigdem; Chaplin, Paul; Kalla, Markus; Hausmann, Jürgen; Schmittwolf, Carolin; Lauterbach, Henning; Volkmann, Ariane; Hochrein, Hubertus; Medina-Echeverz, José.
Afiliación
  • Hinterberger M; Bavarian Nordic GmbH, Fraunhoferstr.13, 82152, Planegg, Germany. mahi@bavarian-nordic.com.
  • Endt K; Bavarian Nordic GmbH, Fraunhoferstr.13, 82152, Planegg, Germany.
  • Bathke B; Bavarian Nordic GmbH, Fraunhoferstr.13, 82152, Planegg, Germany.
  • Habjan M; Bavarian Nordic GmbH, Fraunhoferstr.13, 82152, Planegg, Germany.
  • Heiseke A; Bavarian Nordic GmbH, Fraunhoferstr.13, 82152, Planegg, Germany.
  • Schweneker M; GlaxoSmithKline GmbH, Prinzregentenpl. 9, 81675, Munich, Germany.
  • Von Rohrscheidt J; Bavarian Nordic GmbH, Fraunhoferstr.13, 82152, Planegg, Germany.
  • Atay C; Bavarian Nordic GmbH, Fraunhoferstr.13, 82152, Planegg, Germany.
  • Chaplin P; Origenis GmbH, Am Klopferspitz 19A, 82152, Planegg, Germany.
  • Kalla M; Bavarian Nordic GmbH, Fraunhoferstr.13, 82152, Planegg, Germany.
  • Hausmann J; Bavarian Nordic GmbH, Fraunhoferstr.13, 82152, Planegg, Germany.
  • Schmittwolf C; Bavarian Nordic GmbH, Fraunhoferstr.13, 82152, Planegg, Germany.
  • Lauterbach H; Bavarian Nordic GmbH, Fraunhoferstr.13, 82152, Planegg, Germany.
  • Volkmann A; Bavarian Nordic GmbH, Fraunhoferstr.13, 82152, Planegg, Germany.
  • Hochrein H; Bavarian Nordic GmbH, Fraunhoferstr.13, 82152, Planegg, Germany.
  • Medina-Echeverz J; Hookipa Pharma Inc, 350 Fifth Avenue, Room/Suite 7240, New York City, NY, USA.
Sci Rep ; 13(1): 5162, 2023 03 30.
Article en En | MEDLINE | ID: mdl-36997583

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vacunas contra el Cáncer / Neoplasias Tipo de estudio: Prognostic_studies Idioma: En Revista: Sci Rep Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vacunas contra el Cáncer / Neoplasias Tipo de estudio: Prognostic_studies Idioma: En Revista: Sci Rep Año: 2023 Tipo del documento: Article